JP Patent

JP6846343B2 — 特に注意欠陥障害の治療のための方法および組成物

Assigned to Purdue Pharma LP · Expires 2021-03-24 · 5y expired

What this patent protects

Patent listed against methylphenidate-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP6846343B2
Jurisdiction
JP
Classification
—
Expires
2021-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Purdue Pharma LP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.